Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Plasma-parathyroid hormone is associated with subclinical and clinical atherosclerotic disease in 2 community-based cohorts.

Hagström E, Michaëlsson K, Melhus H, Hansen T, Ahlström H, Johansson L, Ingelsson E, Sundström J, Lind L, Arnlöv J.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1567-73. doi: 10.1161/ATVBAHA.113.303062. Epub 2014 Mar 13.


Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts.

Hagström E, Kilander L, Nylander R, Larsson EM, Michaëlsson K, Melhus H, Ahlström H, Johansson L, Lind L, Arnlöv J.

J Clin Endocrinol Metab. 2014 Nov;99(11):4181-9. doi: 10.1210/jc.2014-1736. Epub 2014 Aug 20.


Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort.

Hagström E, Ahlström T, Ärnlöv J, Larsson A, Melhus H, Hellman P, Lind L.

Atherosclerosis. 2015 Feb;238(2):420-6. doi: 10.1016/j.atherosclerosis.2014.12.027. Epub 2014 Dec 20.


Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J.

Circulation. 2009 Jun 2;119(21):2765-71. doi: 10.1161/CIRCULATIONAHA.108.808733. Epub 2009 May 18.


Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.

Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, Shoben AB, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH.

J Am Heart Assoc. 2014 Dec 2;3(6):e001278. doi: 10.1161/JAHA.114.001278.


Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.

Ärnlöv J, Carlsson AC, Sundström J, Ingelsson E, Larsson A, Lind L, Larsson TE.

Clin J Am Soc Nephrol. 2013 May;8(5):781-6. doi: 10.2215/CJN.09570912. Epub 2013 Jan 18.


Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.

Kamycheva E, Sundsfjord J, Jorde R.

Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):69-74.


Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB.

Am Heart J. 2011 Aug;162(2):331-339.e2. doi: 10.1016/j.ahj.2011.05.005.


Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study.

Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F, Salas-Salvadó J.

Cardiovasc Diabetol. 2012 Dec 11;11:149. doi: 10.1186/1475-2840-11-149.


Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.

Grandi NC, Breitling LP, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H.

Heart. 2011 Aug;97(15):1215-21. doi: 10.1136/hrt.2011.223529. Epub 2011 May 17.


Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts.

Ärnlöv J, Ruge T, Ingelsson E, Larsson A, Sundström J, Lind L.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2689-95. doi: 10.1161/ATVBAHA.113.301704. Epub 2013 Sep 12.


Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism.

Stamatelopoulos K, Athanasouli F, Pappa T, Labrinoudaki I, Papamichael C, Polymeris A, Georgiopoulos G, Vemmou A, Sarika L, Terpos E, Alevizaki M.

J Clin Endocrinol Metab. 2014 Aug;99(8):2704-11. doi: 10.1210/jc.2013-4273. Epub 2014 May 19.


Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography.

Siddiqui S, MacGregor MS, Glynn C, Roditi G, Deighan CJ.

Am J Kidney Dis. 2005 Dec;46(6):1065-73.


Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes.

Lau KK, Wong YK, Chan YH, Yiu KH, Teo KC, Li LS, Ho SL, Chan KH, Siu CW, Tse HF.

Cardiovasc Diabetol. 2012 Aug 18;11:101. doi: 10.1186/1475-2840-11-101.


Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.

Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellström D, Lind L, Ohlsson C, Larsson TE.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):219-27. doi: 10.1161/ATVBAHA.110.214619. Epub 2010 Oct 21.


Soluble tumor necrosis factor receptor 1 (sTNFR1) is associated with increased total mortality due to cancer and cardiovascular causes - findings from two community based cohorts of elderly.

Carlsson AC, Juhlin CC, Larsson TE, Larsson A, Ingelsson E, Sundström J, Lind L, Arnlöv J.

Atherosclerosis. 2014 Nov;237(1):236-42. doi: 10.1016/j.atherosclerosis.2014.09.005. Epub 2014 Sep 16.


Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study.

Korada SK, Zhao D, Gottesman RF, Guallar E, Lutsey PL, Alonso A, Sharrett AR, Post WS, Reis JP, Mosley TH, Michos ED.

J Stroke Cerebrovasc Dis. 2016 Apr;25(4):883-93. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.029. Epub 2016 Jan 26.


The prevalence and quantification of atherosclerosis in an elderly population assessed by whole-body magnetic resonance angiography.

Hansen T, Wikström J, Johansson LO, Lind L, Ahlström H.

Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):649-54. Epub 2006 Dec 14.


Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.

Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H.

Transplantation. 2015 Feb;99(2):351-9. doi: 10.1097/TP.0000000000000583.


Supplemental Content

Support Center